Swiss Medical Weekly
● SMW Supporting Association
Preprints posted in the last 90 days, ranked by how well they match Swiss Medical Weekly's content profile, based on 15 papers previously published here. The average preprint has a 0.01% match score for this journal, so anything above that is already an above-average fit.
Leuenberger, L. M.; Shoman, Y.; Romero, F.; Sasaki, M.; Deligianni, X.; Goebel, N.; Mozun, R.; Bielicki, J. A.; Burckhardt, M.-A.; Saner, C.; Schwitzgebel, V.; Hauschild, M.; Righini Grunder, F.; Mueller, P.; Schlapbach, L. J.; Jenni, O.; Spycher, B. D.; Kuehni, C. E.; Belle, F. N.; SwissPedHealth consotrium,
Show abstract
BACKGROUND: We used anthropometric data from electronic health records (EHRs) of Swiss childrens hospitals to evaluate growth references and estimate centile curves. METHODS: We received EHRs extracted from seven Swiss childrens hospitals and analysed two samples: all children with a height, weight, body mass index (BMI), or head circumference recording, and a subsample restricted to children without diseases potentially affecting growth, weighted to represent the general population. We calculated mean z-scores based on the World Health Organization growth references adopted for Switzerland in 2011 (CH-WHO 2011) and current Swiss growth references (Swiss 2026). We estimated sex-specific centile curves in the subsample using generalised additive models for location, scale, and shape. RESULTS: We included 213,868 children with height, 448,002 with weight, 209,244 with BMI, and 67,397 with head circumference recordings. Mean z-scores in the all children sample were (CH-WHO 2011; Swiss 2026): height (0.10; -0.19), weight (0.16; -0.09), BMI (0.04; -0.07), head circumference (-0.28, -0.28); and in the subsample: height (0.34; 0.00), weight (0.27; 0.01), BMI (0.18; 0.05), and head circumference (0.04; 0.01). The 50th height, weight, BMI, and head circumference centiles of girls and boys in the subsample closely followed those of Swiss 2026, with slightly wider 3rd and 97th centiles in infancy and adolescence. CONCLUSION: Height, weight, BMI, and head circumference centiles aligned well with the Swiss 2026 growth references in Switzerland, demonstrating that hospital EHRs could contribute to future growth references.
Bruns, N.; Wessel, A.; Biedermann, R.; Fiedler, K. M.; Goretzki, S. C.; Greve, S.; Hannes, T.; Felderhoff-Mueser, U.; Heimann, K.; Mand, N.; Masjosthusmann, K.; Merker, M.; Soler Wenglein, J.; van den Heuvel, I. A.; Westhoff, J. H.; Tsaka, S.; Lieftuechter, V.; Haertel, C.; Dohna-Schwake, C.; Hojeij, R.
Show abstract
Purpose: Outcome consequences of critically ill children treated outside of pediatric intensive care units (PICU) are unknown. We assessed case fatality of children receiving complex intensive care treatment (CICT) by treating department in Germany and explored reasons for admission to adult intensive care units (AICU). Methods: Retrospective study using the German nationwide hospital discharge dataset 2016 to 2023. Cases aged [≥] 28 days and < 18 years receiving CICT were classified as PICU, AICU, or interdisciplinary by department codes. Odds ratios (OR) for in-hospital case fatality were estimated in generalized linear mixed models with the hospital as random effect, adjusted for age, acute organ dysfunction, and chronic conditions. Excess deaths were estimated and a survey among pediatric and adult intensivists was analyzed qualitatively. Results: Of 143,034 cases, 67.8 % were treated in PICUs, 14.0 % in AICUs, and 18.2 % were interdisciplinary. The crude OR for death in PICUs versus AICUs was 1.14 (95 % CI 1.03 to 1.26), reversing to 0.73 (0.63 to 0.84) after adjustment. For PICU and interdisciplinary cases combined versus AICU, the fully adjusted OR was 0.61 (0.54 to 0.70). Estimated excess deaths across the study period were 100, rising to 191 when interdisciplinary cases counted as pediatric. Capacity constraints, organizational factors, and clinical expertise were the main domains underlying AICU admissions. Conclusions: Children treated outside of PICUs had higher risk-adjusted case fatality, while crude figures pointed in the opposite direction. The findings support treating critically ill children in settings with routine pediatric intensive care experience.
Ruesta-Maijala, A.; Lehtonen, T.; Sane, J.; Leino, T.
Show abstract
Background Severe acute respiratory infections (SARI) strain healthcare systems. Sentinel surveillance remains central to SARI monitoring, but routinely collected hospital discharge data offer a scalable, population-wide complement. In Finland, national registers now enable register-based surveillance, yet SARI case definitions remain unevaluated. Aim To evaluate whether routinely collected electronic health records can support register-based SARI surveillance and establish a national case definition. Methods We conducted a retrospective register-based study linking inpatient discharge data from the Finnish Care Register for Health Care (Hilmo) and laboratory-confirmed pathogen notifications from the National Infectious Diseases Register (NIDR). Admissions were aggregated into hospitalisation episodes using generic and pathogen-specific respiratory ICD-10 codes and linked to laboratory-confirmed respiratory pathogens within an admission-centred window. We assessed the impact of diagnostic coding position, laboratory linkage windows and alternative case definitions on age distribution, seasonality and epidemic trend detection. Results We included 145,435 respiratory hospitalisation episodes. Laboratory confirmations clustered around admission, and a -7-to-+3-day window was selected; 51,498 (35.4%) had a linked laboratory confirmation. Specific primary-position diagnoses preserved clear seasonality and age distributions consistent with SARI epidemiology, whereas secondary-position diagnoses showed attenuated seasonality. A combined case definition incorporating specific primary diagnoses and laboratory-supported syndromic episodes produced stable epidemic curves while improving sensitivity over laboratory confirmation alone. Conclusion National discharge and laboratory registers can support robust SARI surveillance in Finland when case definitions are carefully designed. A combined register-based definition balances specificity, sensitivity and feasibility, complementing sentinel surveillance and integrated respiratory monitoring. Keywords Severe acute respiratory infection (SARI); surveillance; electronic health records; ICD-10; case definition; Finland
Westfall, M. N.; Hoiby, N.; Rasmussen, S.; Ziock, H.-J.
Show abstract
To deal with the COVID-19 pandemic, Denmark implemented an aggressive program aimed at controlling the pandemic which included both testing and contact tracing programs. The large amount of data collected in Denmark on the pandemic and its integrated nature made it possible to investigate the effectiveness of the testing and contact tracing effort. The results of that investigation and a discussion of the effectiveness and limitations of the different control efforts are reported herein, as are lessons learned concerning possible improvements for the future. The analysis is limited to the period from the start of the COVID-19 pandemic in Denmark (late Feb. 2020) into May 2021, at which time the impact of vaccination intervention was already playing a role with ~25% of the Danish population at least partially vaccinated. From the available data sets we estimate the national Infection Detection Efficiency (IDE) starting around July 1, 2020, the time at which the national infection detection program started to be implemented in a more robust form. The results rely on daily COVID-19 hospital admissions, PCR test results, and anti-body prevalence values for the Danish population. We find that for the long-term average, the combined Danish national testing and contact tracing program identified on average about 55 to 60% of the infected individuals during the period from Sept. 1, 2020, into early May 2021. However, higher infection detection efficiencies were achieved in localized areas for short time intervals. Our investigations further indicate that the Danish testing and contact tracing program, which was among the most ambitious in the world, could have had a better balance between voluntary probing on the one hand and focused contact tracing and targeted testing on the other hand. As typically implemented, it proved to be largely ineffective in controlling the pandemic. However, in at least one case when it was implemented in an enhanced and focused mode, it was able to bring a large local outbreak that dominated the country's cases under control. We have compiled a list of lessons learned regarding the use of contact tracing procedures to control potential future pandemics before vaccinations become available.
Fairweather, A. G.; Swallow, B.; Stuart, R. M.; Kerr, C. C.; Bonell, C.; Viner, R. M.; Panovska-Griffiths, J.
Show abstract
Background/Objectives We evaluated the impact of the COVID-19 adolescent vaccination in England at two different epidemic points: the autumn (August-November) 2021, in the presence of a large Omicron epidemic wave, and the autumn (August-November) 2022, when the subsequent Omicron epidemic was at an endemic stage. Methods Using the Covasim SARS-CoV-2 model for England, under varying vaccine uptake and onset time, we evaluated the impact of a)vaccinating 18+ only versus additional 12+ vaccination from the autumn 2021; and b)the current immunisation strategy at the time versus additional 12+ vaccination from September 2022, projecting the number of new daily SARS-CoV-2 infections, hospitalisations and deaths. Results In presence of the BA.1 Omicron wave in late 2021, the expanded adolescent vaccination averted ~3,000,000 cases across all-ages, ~1,010,000 SARS-CoV-2 infections in the period 2-6 months from vaccine onset in the vaccinated cohort. During the Omicron waves in 2022, additional adolescents vaccination did not significantly reduce the COVID-19 burden in the entire population, nor within the vaccinated cohort. Conclusions Our findings highlight that adolescent vaccination impact depends on the timing/speed of implementation, other present intervention strategies, and the status of the epidemic at the time and it should not be considered as a stand-alone immunisation strategy.
Krasnova, T.; Zarkovic, M.; Nigg, C.; Sasaki, M.; Ganbat, M.; Casaulta, C.; Moeller, A.; Kuehni, C. E.
Show abstract
Background Exposure to environmental tobacco smoke (ETS) negatively affects children`s health, but few studies examined parental smoking behaviour in families of children with respiratory diseases. We studied parental smoking prevalence, characteristics, and changes over one year among families in the Swiss Paediatric Airway Cohort (SPAC). Methods We included children aged 0-17 years referred to paediatric respiratory outpatient clinics in Switzerland from 2017 to 2024. Parents answered a questionnaire at the initial clinic visit and again after one year. We used multivariable logistic regression to explore the characteristics of mothers and fathers who smoked and assessed changes in smoking behavior over one year. Results Among 4,199 children (median age 9 years [IQR 5-12]), 31% were exposed to parental smoking at baseline (paternal smoking: 16%; maternal smoking: 6%; both parents smoking: 9%). Mothers were more likely to smoke if they had a lower education level (OR 2.0, 95%CI 1.6-2.5 for compulsory education vs university education), did not have Swiss nationality (OR 1.3, 1.0-1.6) and lived in a socially disadvantaged neighborhood (OR 1.3, 1.0-1.7). Similar associations were observed for fathers. In addition, fathers were more likely to smoke if they were unemployed (OR 2.0, 1.3-3.2 vs having a full-time job. The strongest predictor of smoking was having a partner who smoked, with ORs above 6 for both mothers and fathers. Parents of 2,338 children completed the one-year follow-up questionnaire. Data from 2226 mothers and 1895 fathers showed that among baseline smokers with follow-up data, 225 (78%) mothers and 382 (81%) of fathers continued smoking, and only 63 (22%) of mothers and 90 (19%) of fathers quit. Among baseline non-smokers, 47 (2%) mothers and 54 (3%) fathers started smoking. Conclusions One-third of children consulting respiratory specialists in Switzerland are exposed to parental smoking. ETS exposure was strongly associated with socio-economic factors. Even after visiting a specialized clinic, most parents continued to smoke. This highlights the urgent need for stronger national smoking policies and targeted support to help these parents quit and stay smoke-free.
Nazzari, V.; Navarro Gallinad, A.; Ghirardi, L.; Gianbartolomei, C.; Paganoni, A. M.; Bardaji, A.; Zuccolo, L.
Show abstract
BackgroundCOVID-19 pandemic modified trends of infant bronchiolitis, leading cause of emergency room (ER) attendance in infants in high income countries, primarily due to Respiratory Syncytial Virus. Understanding recent pandemic-related epidemiological shifts could inform affordable prevention efforts to improve sustainability and coverage of prophylactic treatments beyond maternal vaccines and infant monoclonal antibodies. MethodsWe estimated incidence rates (IR) of bronchiolitis ER presentations in 0-6month olds in 2012-2023 in a region-wide cohort of almost 1 million births using administrative health data from Lombardy, Italy. To assess potential contributors, we investigated direct and indirect COVID-19-related factors, including disease severity, shape of the epidemic peak, parental health seeking behaviour and vaccine coverage. We estimated COVID-19 maternal vaccination associations using mothers-infants data linkages and multivariable-adjusted logistic regression. FindingsCompared to pre-pandemic levels, IRs doubled in 2021-2023 (from 2 to [≥] 4/100 person-time). The surge could not be explained by changes in infant age at ER visit, clinical severity or in the shape of the epidemic peak. Adjusted models showed little support for a role of infant routine or maternal COVID-19 vaccination on bronchiolitis episodes (respectively hazard ratio 1.09, 95%CI: 0.98-1.22 and odds ratio 0.91, 95%CI: 0.76-1.09). InterpretationThe post-pandemic increase in infant bronchiolitis is likely driven by multiple epidemiological changes rather than a single factor. As maternal RSV vaccination and infant RSV monoclonal antibodies are introduced and scale up, identifying these mechanisms will be critical to maximise their public health impact, inform complementary prevention strategies, and improve preparedness for future RSV epidemics.
Ho, N. T.; Tran, K. P. M.
Show abstract
Background Inadequate spectacle correction limits the benefit of school vision screening, yet most evidence addresses only whether a child owns glasses rather than whether those glasses work. This study examined the prevalence, predictors, and persistence of inadequate spectacle correction among schoolchildren in three Vietnamese cities. Methods We analyzed annual vision screening records of students from a private school network in Ha Noi, Ho Chi Minh City, and Hai Phong, 2021 to 2024. Inadequate correction was defined as visual acuity below the age-appropriate threshold despite current glasses. A population-averaged modified-Poisson regression with robust standard errors, clustered by child, estimated adjusted prevalence ratios (aPR) for city, age, sex, and calendar year. Children linked across consecutive years allowed persistence analysis. Results Among 39,697 spectacle-wearing examinations, 30,936 (77.9%) were inadequately corrected, ranging from 64.8% (95%CI= 63.9, 65.8) in Ho Chi Minh City to 96.7% (96.0, 97.3) in Hai Phong. After adjustment, prevalence was lower in Ho Chi Minh City (aPR= 0.76; 95%CI= 0.75, 0.78; p<0.001) and higher in Hai Phong (aPR= 1.25; 95%CI= 1.23, 1.26; p<0.001) relative to Hanoi, and fell with age (aPR= 0.97 per year; 95%CI= 0.96, 0.97; p<0.001). Among 9,285 linked year pairs from 8,341 children, 85.3% (84.4, 86.1) of initially inadequately corrected children remained so the following year. Conclusions Most spectacle-wearing children in this Vietnamese cohort were inadequately corrected, with wide geographic variation and high persistence. School vision programs need mechanisms to verify correction adequacy after glasses are dispensed, not only to detect refractive error.
Ho, N. T.; Tran, K. P. M.
Show abstract
Background. Refractive error is a leading cause of childhood visual impairment worldwide, yet longitudinal, multi-city data from Vietnam remain scarce, especially for children younger than school age. We aimed to describe the prevalence and secular trends of refractive error in a large urban Vietnamese school health program. Methods. We conducted a retrospective analysis of repeated cross-sectional school health screening data collected from 2021 to 2024 across three major Vietnamese cities (Hanoi, Ho Chi Minh City, and Hai Phong), among children aged 3 to 18 years. The dataset included 141,339 examinations, with a Hanoi sub-cohort of 19,788 examinations that had quantitative autorefractor measurements. We estimated crude prevalence and adjusted prevalence ratios using Poisson regression. Results. The prevalence of any refractive error stayed high throughout the study period, ranging from 53.9% to 57.1% (P for trend < 0.001), and was higher in Hai Phong (68.4%) and Hanoi (61.6%) than Ho Chi Minh City (35.9%), higher in girls than boys (58.5% vs 53.1%), and higher with older age (P < 0.001). In the Hanoi sub-cohort, confirmed myopia prevalence nearly tripled, from 3.7% in 2022 to 11.0% in 2024 (P < 0.001), while hyperopia declined. Conclusions. Refractive error is highly prevalent among urban Vietnamese schoolchildren, and confirmed myopia appears to be rising rapidly at younger ages. These findings support closer surveillance and earlier school-based intervention in Vietnam and similar settings.
Wolmuth-Gordon, H.; Lachhani, M.; Pebody, R.; Amirthalingam, G.; Green, R. E.; Dabrera, G.
Show abstract
Background FluSurvey is a participatory surveillance system, through which participants report weekly respiratory symptoms, healthcare use and social contacts. To support rapid public health assessment we developed a respiratory self-swabbing feature. We aimed to assess the feasibility of self-swabbing among symptomatic FluSurvey participants. Methods FluSurvey self-swabbing was deployed in England between January-March 2026. Adults reporting recent Acute Respiratory Infection symptoms were eligible for a self-swabbing Covid-19, RSV and Influenza PCR test which was returned to the laboratory by post. Participants were sent optional feedback surveys. We described swabbing interest, timeliness and participant demographics. We evaluated participant feedback to improve the process. Results There were 234 eligible illnesses during the study period; 45.7% (107/234) requested test kits and 93.5%(100/107) test kits were returned. Of these, 97.0%(97/100) had valid results; median participant age was 61.74 years (IQR:47.4-67.4), 68.4% were female and 90.0% were of white ethnicity. All nine regions in England were represented. Timeliness was high; the median time from symptom onset to specimen date was 4.0 days (IQR:3.0-5.0). Of participants completing feedback surveys, 96.7%(59/61) would consider participating in self-swabbing again. Conclusions We developed a tool to test individuals, often not presenting to healthcare, for respiratory viruses using an established community-based surveillance system. This tool can be rapidly deployed and adapted to public health need, to assess community-based emerging respiratory or pandemic infections. The high return rate and positive feedback suggest continued engagement of the cohort in respiratory virus swabbing.
Hojeij, R.; Oenning, C.; Ravichandrajah, H.; Haertel, C.; Dohna-Schwake, C.; Felderhoff-Mueser, U.; Bruns, N.
Show abstract
Background: Socioeconomic deprivation is associated with childhood morbidity, but nationwide evidence on critical illness and death in a health system with universal insurance coverage is scarce. We assessed the association between area-level deprivation and the population-level incidence of hospital admission, complex intensive care treatment (CICT), and CICT-related mortality in German children, and changes over time. Methods: Population-based analysis of complete German hospital discharge data, 2016 to 2023, covering all cases aged > 28 days to < 18 years. Cases were linked to the German Index of Socioeconomic Deprivation (GISD) via the municipality of residence and grouped into quintiles (Q1 least, Q5 most deprived). Incidence rates were calculated per 100,000 child years. Negative binomial regression adjusted for calendar year, with population as offset, yielded adjusted incidence rate ratios (aIRR) per one-quintile increase in deprivation; sensitivity analyses additionally adjusted for age group. Excess cases were estimated by applying Q1 incidence rates to Q2 to Q5. Results: Of 8,890,103 pediatric cases, 140,509 (1.6 %) received CICT and 3,386 (2.40 %) of these died. Incidence rose with deprivation from Q1 to Q5: admissions 6,191 to 9,255 per 100,000 child years, CICT 97 to 128, mortality 2.54 to 2.96. Each one-quintile increase was associated with higher risk of admission (aIRR 1.10, 95 % CI 1.10-1.11), CICT (1.07, 1.05-1.08), and mortality (1.04, 1.01-1.06); estimates were unchanged after age adjustment. Relative to Q1 rates, Q2 to Q5 accounted for 1,295,896 excess admissions (20.8 %), 11,254 excess CICT cases (12.6 %), and 194 excess deaths (8.7 %). Case fatality among CICT cases was lower in more deprived quintiles (2.35 % in Q5 versus 2.64 % in Q1), as were organ dysfunction and chronic conditions. Disparities in admission and CICT narrowed over time, whereas the mortality gradient persisted. Conclusions: Universal health insurance did not eliminate socioeconomic inequalities in pediatric critical illness. Deprivation increased the population burden of admission, intensive care, and death, but did not worsen outcomes once intensive care had begun, indicating that inequalities arise before pediatric intensive care and that prevention upstream in the care continuum is the primary target.
Kupek, E.
Show abstract
Background: A large increase in mortality from severe acute respiratory infections (SARI) in Brazil in 2025 was mainly driven by influenza A and respiratory syncytial virus (RSV) among children and the aged, but 2026 data remain largely unpublished. Methods: Secondary data on SARI by age group (<2, 2-4, 5-14, 15-49, 50-64, 65+ years) and virus (Influenza A/B, RSV, SARS-CoV-2, adenovirus, rhinovirus, bocavirus, and metapneumovirus) were retrieved for 35 weeks of 2026. Weekly variations in infection rate (IR) and mortality rate (MR) were described by virus and age group. Case fatality ratio (CFR) and vaccine-preventable deaths from influenza, RSV, and SARS-CoV-2 were analysed by age group. Missing virus classification was estimated by multinomial regression. Poisson-based 95% confidence intervals (CI) were calculated for MR. Results: Influenza A infections quintupled during February and March, with a mortality peak in April, mainly due to H2N3. RSV and rhinovirus caused more deaths than influenza viruses, especially among young children (<2) and the aged (65+). The former were most frequently infected by RSV and the latter by rhinovirus. For those 50 years or older, influenza B reached a CFR of about 20%, compared with 5-15% for influenza A, metapneumovirus, rhinovirus, and other non-subtyped viruses. The highest vaccine-preventable MRs per 100,000 were 17.23 for the oldest and 8.62 for the youngest. Under ideal conditions, 6418 lives could have been saved, about half among children and adolescents <15 years old. Conclusions: Vaccine-preventable SARI in Brazil exerted a high toll in fall and winter 2026, mainly due to influenza A, RSV, and rhinovirus. Better vaccine coverage may significantly reduce this toll.
de Araujo Morais, J. H.; Dias Ferreira, C.; Saraceni, V.; Medeiros de Oliveira Cruz, D.; Mateus Oliveira Aguilar, G.; Cruz, O. G.
Show abstract
Motivation: With the scaling frequency and intensity of extreme heat events across the globe, it is critical for public institutions to develop early detection systems and continuous monitoring of these events and their impacts. In Brazil, Rio de Janeiro was the first city to publish its heat protocol, with the Rio Heat Dashboard as a central component of this system. Implementation: The dashboard was implemented using R/Shiny and integrates climatic and health data from multiple sources. General features: The application comprises real-time heat exposure monitoring and automatic alert level classification, which is monitored daily by multiple municipal actors and supports activation of actions specified in the heat protocol. It also features a health impact module, which lists each heat event and its impact on mortality, and primary care and emergency visits. Availability: The source for full reproducibility is available through https://github.com/joaohmorais/RioHeatDashboard.
Barbier, M.; Levy, C.; Cohen, R.; Valtuille, Z.; Assad, Z.; Yang, J.-s.; Fafi, I.; Lenglart, L.; Bechet, S.; Osei, L.; Launay, E.; Gras Le Guen, C.; Gajdos, V.; Jeziorski, E.; De Pontual, L.; Basmaci, R.; Rameix-Welti, M.-A.; Ouldali, N.; Fourati, S.; French RSV Surveillance Network,
Show abstract
Importance: Nirsevimab, a monoclonal antibody against RSV, was implemented in France in September 2023. Recently, rare resistance-associated substitutions were described in RSV but the effectiveness according to lineages remains unclear. Objective: We aimed to estimate the effectiveness of nirsevimab against hospitalization for RSV bronchiolitis according to RSV lineages. Design: We conducted a multicenter test-negative case-control study from October 15, 2023 to March 15, 2025. Setting: This study was based on data from three national multicentric prospective studies. The 12 participating centers were secondary or tertiary hospital with a pediatric department located in France. Participants: We included all children younger than 12 months who were hospitalized for RSV bronchiolitis in one of the participating centers in France during the two first RSV epidemic seasons following the implementation of nirsevimab (from October 15, 2023 to February 29, 2024, and from October 10, 2024 to March 15, 2025). Main outcomes and measures: The main outcome of the study was the RSV test result of bronchiolitis cases. RSV whole-genome sequencing was performed using a tiled amplicon approach covering the complete viral genome, as previously described in the POLYRES studies. We estimated the effectiveness of nirsevimab by a multivariable logistic regression model adjusted for potential confounders. We estimated the adjusted risk of immunization failure for each lineage by calculating relative odds ratio to a reference lineage. A range of sensitivity analyses were conducted. Results: We included 3019 infants with bronchiolitis among which 2273 had a positive RSV test (case patients) and 746 had a negative RSV test (control patients). Overall, 373/2273 (16.4%) case patients were immunized by nirsevimab versus 423/746 (56.7%) control patients. The adjusted effectiveness of nirsevimab against hospitalization for bronchiolitis was 88.4% (95% CI, 84.5-91.4) with RSV-B and 79.4% (95% CI, 73.7-83.8) with RSV-A. The risk of immunization failure was 3.2-fold (95% CI 1.8-5.7) higher for lineages derived from A.D.3 than for lineages derived from B.D.4.1. Conclusion and relevance: In this multicentric case-control study, we observed that nirsevimab effectiveness was variable across RSV lineages, with a lower effectiveness against A.D.3 lineages compare to others. Further surveillance is needed to confirm these findings and assess their implication on RSV lineages epidemiology as nirsevimab use expands.
Nyman, R. B. E.
Show abstract
Official outbreak counts are authoritative but published with delay. Between situation reports, a response team either works from a number that is several days old or extrapolates the official trend forward. We assess whether open-source reporting can reduce this gap. On the 2026 DRC Ebola outbreak we reconstruct the cumulative case and death curves from open sources, anchor them to the latest official figure, and project to the present. In a real-time (vintage) backtest over roughly ten weeks, using only reports available at each point, the open-source nowcast is comparable to simple extrapolation when the official figure is fresh, but once the official figure is stale by four to five days for cases, and about six for deaths, it is materially more accurate, cutting the median case-count error by about two thirds (12.6% to 3.9%) at a one-week lag. The advantage is concentrated at the phase transitions, where the official trend turns and any extrapolation of it is furthest from the truth: there the open-source nowcast roughly halves the error of extrapolation for both cases and deaths, while in steady periods the two are comparable and the added value is small. During fast growth the estimate has an asymmetric downside tail, so decisions between reports should rest on the interval, not the point alone.
Lin, F.; Bischops, A. C.; Kerth, J.-L.; Meissner, T.; Bruni, T.; Eickhoff, S. B.; Heinrichs, B.; Lahnakoskia, J. M.; Dukart, J.
Show abstract
With the rapid advancement of artificial intelligence (AI) technologies, growing interest has emerged in its potential application in pediatric healthcare. Understanding the factors influencing AI acceptability among parents and clinical staff is an important prerequisite for facilitating its integration in clinical routine. To date, these factors have not been systematically assessed across different stakeholder groups. Here we investigated AI acceptability among parents (first cohort n = 198; second cohort: n = 79) and pediatric health care professionals (n = 33) across different disease, diagnosis or treatment scenarios. The effects of demographic variables and contextual predictors, such as data privacy, AI knowledge and perceived disease severity, on willingness to use AI were evaluated. More liberal data privacy was associated with reduced willingness to use AI (p = < .001). A higher perceived disease severity was linked to higher willingness to use AI ({beta} = .10, p = .013) in the second parent group. When the recommendations of AI and clinicians conflicted, parents were more likely to choose AI over the judgment of clinicians in treatment compared to diagnosis scenarios. Healthcare professionals showed similar patterns but additionally weighted perceived disease severity when resolving disagreements. These findings highlight the importance of addressing stakeholder concerns regarding disease specific customization, accuracy, data privacy and accountability when introducing AI into pediatric healthcare settings.
Ho, N. T.; Tran, K. P. M.
Show abstract
PurposeTo examine the association between BMI-for-age z-score (BAZ) and BMI status with refractive error prevalence, incidence, subtypes, and quantitative refraction in Vietnamese schoolchildren. MethodsWe retrospectively analyzed body mass index and refractive error data from annual school health checks in three Vietnamese cities, 2022 to 2024. The main analysis set was restricted to children age 6 and older (49,415 examinations, 31,522 children). Refractive error subtypes and quantitative refraction came from a Hanoi autorefractor sub-cohort (13,059 examinations). We used sex-stratified Poisson models with generalized estimating equations, adjusted for age, city, and year, plus linear mixed models for quantitative outcomes. ResultsAny refractive error followed a U shaped curve across BAZ in both sexes, significant in girls (prevalence ratio 1.01 per 1-SD BAZ, p = 0.027) but not boys (p = 0.099). Obesity was associated with higher any refractive error prevalence in girls (adjusted prevalence ratio 1.05, p = 0.017). Astigmatism was associated with BAZ in both sexes (p < 0.001), anisometropia in boys only (p < 0.001), with no association for myopia or hyperopia. Spherical equivalent shifted slightly toward hyperopia, not myopia, with higher BAZ. A supplementary check over 1 to 2 years found no evidence that prior BAZ predicted new refractive error onset (prevalence ratio 1.02, p > 0.6 in both sexes), and the nonlinear pattern did not reappear. ConclusionsAdiposity relates cross-sectionally to refractive error in a nonlinear, sex specific way concentrated in astigmatism and anisometropia rather than myopia, though this did not hold up short term.
Reddy, V.; Reddy, S. V.; Ram, V.; K, N.
Show abstract
Automated surveillance systems can prove to be extremely useful in detecting outbreaks of respiratory diseases that need further epidemiological investigation. In order for the system to be effective, careful attention has to be paid to the baseline used, absence of the observations, and the use of proper statistical methods. As a solution, the paper describes EpiAlert, a weekly surveillance system based on CDC FluView ILINet. The system is able to transform the number of ILI visits and the total number of visits into a ILI prevalence for the region, create the first reference from the three previous years using a +/- 2-week interval, transform the rate value, and apply two different detectors - CUSUM and EWMA. CUSUM is set at k=0.5 and h=5, whereas EWMA uses {lambda}=0.2 and H=2.7 values. Among the 55 districts, the system gives 45,138 pieces of information about the disease by transforming 44,297 pieces of data into alerts. It is found that there are 2,820 alerts in total (out of which 2,711 alerts used CUSUM, 402 used EWMA, and 293 used both detectors). Additionally, the experiments show that the sensitivity of the device depends greatly on the detector. The latest statistics can be tracked in the report for week 37 of 2026 that recently concluded in West.
Peyton, C.; Luke, C.; Bos, A. F.; Boswell, L.; Finn, C.; deRegnier, R.-A.; Goetgeluck, A.; Gordon, A.; Mann, I.; Stein, K.; Thorley, M.; Boyd, R. N.; Moulton, T.
Show abstract
AIM: To evaluate whether selective motor control quantified from spontaneous infant movement recordings provides diagnostic and prognostic information for cerebral palsy (CP) beyond established movement-based assessments. METHOD: This multicenter diagnostic and prognostic accuracy study included 302 infants (151 with CP) with spontaneous movement recordings obtained between 10 and 20 weeks corrected age from cohorts in Australia and the United States. All eligible infants with CP were included, and a comparison sample without CP was randomly selected. Recordings were scored using the Baby Observational Selective Control Appraisal (BabyOSCAR), Motor Optimality Score Revised (MOS-R), and General Movements Assessment (GMA). Outcomes at 2 years or older included CP diagnosis, Gross Motor Function Classification System (GMFCS) level, and motor distribution. RESULTS: BabyOSCAR discriminated CP diagnosis (area under the curve [AUC] 0.98), including children later classified in GMFCS level I. Among infants with CP, BabyOSCAR discriminated GMFCS levels I - II from III - V (AUC 0.89). BabyOSCAR absolute asymmetry also discriminated unilateral CP from all other infants (AUC 0.90). Diagnostic discrimination was also observed for MOS-R (AUC 0.94) and GMA (AUC 0.86). INTERPRETATION: Quantifying selective motor control from brief infant movement recordings may provide complementary early information about CP diagnosis, functional level, and motor distribution.
Kuhn, A.; Klauser, A.-L.; Engel, J.; Herrmann, A.; Hackenberg, M.; Matilainen, J.; Mayer, S.; Froelich, S.; Kraegeloh-Mann, I.; Groeschel, S.; Janzarik, W. G.
Show abstract
Background Pontocerebellar hypoplasia Type 2A (PCH2A) is a rare, autosomal recessive disorder with reduced life expectancy. Clinical features include profound developmental delay, microcephaly, and a dyskinetic movement disorder. Additional symptoms frequently observed are feeding difficulties, vomiting, dystonic attacks, and seizures. Compared to parents of typically developing children, parents of children with PCH2A experience decreased health-related quality of life. The aim of this study was to provide a follow-up on survival, symptoms, and perceived disease burden. Methods Patients were primarily recruited via the German patients' organization (PCH-Familie e.V.). Inclusion required genetic confirmation of PCH2A. Data were collected from 2020-2022 using parent questionnaires and medical reports; uncertainties were clarified during semi-standardized telephone interviews. Statistical analysis was quantitative, appropriate statistical tests were used, depending on the data distribution. Results Sixty-five patients participated, with a median age of 6.4 years and balanced gender distribution. Sixteen patients (25%) died at a median age of 5.5 years. Ten-year survival rate was 71.5%. Feeding difficulties, dyskinesia, and sleep disturbances were common and persistent symptoms. Seizures increased with age, whereas vomiting and dystonic attacks decreased over time. Perceived disease burden differed among families, but most reported overall impaired quality of life. The most burdensome symptoms were restlessness, sleep disorder, and gastrointestinal issues, while seizures/epilepsy were ranked as least impactful. With increasing age, perceived burden from feeding and swallowing disorders, gastrointestinal problems, episodic abdominal pain, and overall quality of life decreased significantly. Conclusions Life expectancy in PCH2A remains limited, but survival appears to have improved in more recent birth cohorts. Most symptoms persist with age, though a few, like reflux and dystonic attacks, improve in tendency. Conversely, respiratory symptoms and seizures tend to worsen. Notably, perceived disease burden generally decreases as patients age. Restlessness proved to be the most burdensome symptom, although it has not been clearly described before.